Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay

Robert Earl, Linda Sobeski, Denise Timko, Rodney Smith Markin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We developed a method for measuring pentobarbital in samples that also contain phenobarbital. The phenobarbital is destroyed by adding sodium hydroxide and then heating at 95°C for 60 min. Pentobarbital is not affected by this pretreatment and can then be measured with an Abbott TDx barbiturates kit. Using this method, we obtained an average analytical recovery of 98% of added pentobarbital and a correlation of y = 0.953x + 3.4 vs HPLC. The intra-assay CV was 3.7% at 25.8 mg/L; the interassay CV was 6.2% at 16.1 mg/L. Other long-acting barbiturates, e.g., hexobarbital, are also effectively destroyed by this alkali pretreatment. Other short-acting barbiturates, e.g., secobarbital, are not removed and would produce an interference.

Original languageEnglish (US)
Pages (from-to)1774-1777
Number of pages4
JournalClinical Chemistry
Volume37
Issue number10 I
StatePublished - Jan 1 1991

Fingerprint

Fluorescence Polarization Immunoassay
Barbiturates
Pentobarbital
Phenobarbital
Fluorescence
Polarization
Secobarbital
Hexobarbital
Sodium Hydroxide
Alkalies
Heating
Assays
High Pressure Liquid Chromatography
Recovery

Keywords

  • Analytical error
  • Barbiturates

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay. / Earl, Robert; Sobeski, Linda; Timko, Denise; Markin, Rodney Smith.

In: Clinical Chemistry, Vol. 37, No. 10 I, 01.01.1991, p. 1774-1777.

Research output: Contribution to journalArticle

Earl, Robert ; Sobeski, Linda ; Timko, Denise ; Markin, Rodney Smith. / Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay. In: Clinical Chemistry. 1991 ; Vol. 37, No. 10 I. pp. 1774-1777.
@article{ed7bc77f8f0848c7b8a14a0bc47bdb03,
title = "Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay",
abstract = "We developed a method for measuring pentobarbital in samples that also contain phenobarbital. The phenobarbital is destroyed by adding sodium hydroxide and then heating at 95°C for 60 min. Pentobarbital is not affected by this pretreatment and can then be measured with an Abbott TDx barbiturates kit. Using this method, we obtained an average analytical recovery of 98{\%} of added pentobarbital and a correlation of y = 0.953x + 3.4 vs HPLC. The intra-assay CV was 3.7{\%} at 25.8 mg/L; the interassay CV was 6.2{\%} at 16.1 mg/L. Other long-acting barbiturates, e.g., hexobarbital, are also effectively destroyed by this alkali pretreatment. Other short-acting barbiturates, e.g., secobarbital, are not removed and would produce an interference.",
keywords = "Analytical error, Barbiturates",
author = "Robert Earl and Linda Sobeski and Denise Timko and Markin, {Rodney Smith}",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "37",
pages = "1774--1777",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "10 I",

}

TY - JOUR

T1 - Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay

AU - Earl, Robert

AU - Sobeski, Linda

AU - Timko, Denise

AU - Markin, Rodney Smith

PY - 1991/1/1

Y1 - 1991/1/1

N2 - We developed a method for measuring pentobarbital in samples that also contain phenobarbital. The phenobarbital is destroyed by adding sodium hydroxide and then heating at 95°C for 60 min. Pentobarbital is not affected by this pretreatment and can then be measured with an Abbott TDx barbiturates kit. Using this method, we obtained an average analytical recovery of 98% of added pentobarbital and a correlation of y = 0.953x + 3.4 vs HPLC. The intra-assay CV was 3.7% at 25.8 mg/L; the interassay CV was 6.2% at 16.1 mg/L. Other long-acting barbiturates, e.g., hexobarbital, are also effectively destroyed by this alkali pretreatment. Other short-acting barbiturates, e.g., secobarbital, are not removed and would produce an interference.

AB - We developed a method for measuring pentobarbital in samples that also contain phenobarbital. The phenobarbital is destroyed by adding sodium hydroxide and then heating at 95°C for 60 min. Pentobarbital is not affected by this pretreatment and can then be measured with an Abbott TDx barbiturates kit. Using this method, we obtained an average analytical recovery of 98% of added pentobarbital and a correlation of y = 0.953x + 3.4 vs HPLC. The intra-assay CV was 3.7% at 25.8 mg/L; the interassay CV was 6.2% at 16.1 mg/L. Other long-acting barbiturates, e.g., hexobarbital, are also effectively destroyed by this alkali pretreatment. Other short-acting barbiturates, e.g., secobarbital, are not removed and would produce an interference.

KW - Analytical error

KW - Barbiturates

UR - http://www.scopus.com/inward/record.url?scp=0026066294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026066294&partnerID=8YFLogxK

M3 - Article

C2 - 1914183

AN - SCOPUS:0026066294

VL - 37

SP - 1774

EP - 1777

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 10 I

ER -